There is a racial and socioeconomic divide in this country when it comes to the quality of healthcare available to individuals.  Real disparities persist when it comes to investing in new drugs and treatments for diseases that afflict primarily minority populations.  And people of color have traditionally been under-represented in clinical trials, which has profound implications for understanding how new drugs interact with diverse physiologies.

NABB is working to advance the biosciences through initiatives such as:

• Awareness Development (AD): The AD program promotes the development of cultural competence in BIO as a potential strategy to improve quality and eliminate racial/ethnic disparities in health care. Motivation for the AD program is to create specialized healthcare education conferences, seminars, and workshops for industry, government, and clinical science thought leaders to provide case-study analysis and solutions to sector-specific problems in minority healthcare
• Key Opinion Leader (KOL) Development: The KOL development program will identify recruit, train, and manage a core group of national and international experts in scientific, clinical, and regulatory affairs for peer-to peer communications of fair-balanced educational messages related to products that target the healthcare needs of underserved minorities